Ricklefs FL, Drexler R, Wollmann K, Eckhardt A, et al. DNA Methylation subclass Receptor Tyrosine Kinase II (RTK II) is predictive for seizure development in glioblastoma patients. Neuro Oncol 2022 May 2. pii: 6577052. doi: 10.1093.
PMID: 35511473